Our Platform
Approach
Technology
Scientific Materials
Company Materials
LOWE
Pipeline
Who's With Us
Team
Partners
Investors
Investor Relations
ESG
Download Day
Our Story
Story
Mindset
News
Press
Media Kit
Blog
Careers
Our Platform
Approach
Technology
Scientific Materials
Company Materials
LOWE
Pipeline
Who's With Us
Team
Partners
Investors
Investor Relations
ESG
Download Day
Our Story
Story
Mindset
News
Press
Media Kit
Blog
Careers
Blogs
March 12, 2025
No items found.
Leveraging the Power of Patient Data in AI Drug Discovery
January 10, 2025
No items found.
Modeling Animal Data for More Efficient AI Drug Discovery
January 10, 2025
No items found.
Using LLMs for Faster Answers to Deeper Biological Questions for Drug Discovery Research
December 4, 2024
No items found.
Improving Wet Lab Automation with Computer Vision: A Hack Week Breakthrough
November 13, 2024
No items found.
Introducing MolE: A New Model for Predicting Molecular Properties for AI Drug Design and Beyond
November 7, 2024
No items found.
Maps of Biology – and Benchmarks – For All
October 23, 2024
No items found.
Delivering the World’s First Neuromap
October 1, 2024
No items found.
Learning the effects of molecules on cells with MolPhenix
September 11, 2024
No items found.
How Phenomic Foundation Models Are Empowering the Brightfield Comeback
August 28, 2024
No items found.
Brightfield Is Back: A 17th Century Cell Imaging Technique is Making a Comeback Thanks to Machine Learning
August 13, 2024
No items found.
Building, Benchmarking, and Exploring Perturbative Maps of Transcriptional and Morphological Data
May 13, 2024
No items found.
Drug Discovery, STAT! NVIDIA, Recursion Speed Pharma R&D With AI Supercomputer
January 9, 2024
Ben Mabey, M.S.
Nothing Short of Phenomenal: New Deep Learning Model Available on NVIDIA’s BioNeMo Platform
October 26, 2023
Marissa Saunders
Michaela Hatch
How Recursion is Empowering Women Leaders in Utah and Beyond
October 2, 2023
No items found.
An exciting milestone in our partnership with Roche and Genentech
September 1, 2023
Chris Gibson, Ph.D.
Recursion shares perspectives with FDA on using AI and ML in drug discovery and development
August 8, 2023
No items found.
A Deep Dive into Screening 36 Billion Compounds: Q&A with Stephen MacKinnon
July 12, 2023
Ben Mabey, M.S.
Recursion and NVIDIA: Shaping the Future
June 19, 2023
No items found.
Decoding Protein Structures: From AlphaFold to Beyond
June 19, 2023
No items found.
Exploring the Dark Proteome: The Next Frontier in Drug Discovery
June 19, 2023
No items found.
The Science of Drug Rebranding and Repurposing
June 2, 2023
No items found.
HQ Expansion 2023 — Robot Showcase & Murals
April 24, 2023
No items found.
AACR 2023: Recursion's Oncology Breakthroughs
October 5, 2022
No items found.
Anne Carpenter's Vision for Recursion
September 23, 2022
No items found.
The Power of Partnership: Recursion, Roche, and Genentech
June 30, 2022
No items found.
BIO 2022: The Future of AI in Drug Discovery
March 21, 2022
Chris Gibson, Ph.D.
The Genesis of Recursion: Our Origin Story
February 25, 2022
No items found.
Evaluating Python Dependency Managers
December 22, 2021
No items found.
Winter Break: Recursion's Time to Recharge
November 30, 2021
No items found.
A Computer Scientist's Journey at Recursion
November 26, 2021
No items found.
The Essence of Gratitude at Recursion
October 28, 2021
No items found.
My First 90 Days as a Recursionaut
October 8, 2021
Laura Schaevitz
Revolutionizing Disease Assessment with Computer Vision
October 1, 2021
No items found.
Unveiling Hack Week: Innovation at Recursion
September 2, 2021
No items found.
Transitioning from Petroleum to Biotech: A Tale of Change
August 20, 2021
No items found.
Our Commitment to Developer Experience
July 23, 2021
No items found.
Reflecting on Internships at Recursion
August 11, 2020
Chris Gibson, Ph.D.
Sending the Ladder Down: Growth at Recursion
